SABRE trial published in JACC
The SABRE (Sirolimus Angioplasty Balloon for Coronary In-Stent Restenosis) trial was a prospective, single-arm, feasibility study involving 9 European centers to evaluate the safety and effectiveness of the Virtue balloon for coronary ISR, and powered to demonstrate superiority over (historically documented) plain balloon angioplasty treatment.